Journal Mobile Options
Table of Contents
Vol. 64, No. 2, 2011
Issue release date: June 2011
Section title: Review
Free Access
Neuropsychobiology 2011;64:61–85

Functional Neuroimaging in Obsessive-Compulsive Disorder

Del Casale A.a · Kotzalidis G.D.a · Rapinesi C.a · Serata D.a · Ambrosi E.a · Simonetti A.a · Pompili M.a, b · Ferracuti S.a · Tatarelli R.a · Girardi P.a
aNESMOS (Neurosciences, Mental Health, and Sensory Organs) Department, School of Medicine and Psychology, Sapienza University and Sant’Andrea Hospital, Rome, Italy; bMcLean Hospital, Harvard Medical School, Belmont, Mass., USA
email Corresponding Author

Antonio Del Casale, MD

NESMOS (Neurosciences, Mental Health, and Sensory Functions) Department

School of Medicine and Psychology, Sant’Andrea Hospital, Sapienza University

Via di Grottarossa 1035–1039, IT–00189 Rome (Italy)

Tel. +39 063 377 5675, E-Mail


  1. Rasmussen SA, Eisen JL: The epidemiology and differential diagnosis of obsessive compulsive disorder. J Clin Psychiatry 1994;55(suppl):5–10, discussion 11–14.
  2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, American Psychiatric Association, 1994.
  3. Hollander E: Obsessive-compulsive spectrum phenomena and the DSM-V developmental process. CNS Spectr 2008;13:107–108.
  4. Hollander E, Braun A, Simeon D: Should OCD leave the anxiety disorders in DSM-V? The case for obsessive compulsive-related disorders. Depress Anxiety 2008;25:317–329.
  5. Mataix-Cols D, Pertusa A, Leckman JF: Issues for DSM-V: how should obsessive-compulsive and related disorders be classified? Am J Psychiatry 2007;164:1313–1314.
  6. Regier DA: Obsessive-compulsive behavior spectrum: refining the research agenda for DSM-V. Psychiatry Res 2009;170:1–2.
  7. Storch EA, Abramowitz J, Goodman WK: Where does obsessive-compulsive disorder belong in DSM-V? Depress Anxiety 2008;25:336–347.
  8. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593–602.
  9. Geller DA: Obsessive-compulsive and spectrum disorders in children and adolescents. Psychiatr Clin North Am 2006;29:353–370.
  10. Geller DA, Biederman J, Jones J, Shapiro S, Schwartz S, Park KS: Obsessive-compulsive disorder in children and adolescents: a review. Harv Rev Psychiatry 1998;5:260–273.
  11. Heyman I, Fombonne E, Simmons H, Ford T, Meltzer H, Goodman R: Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health. Int Rev Psychiatry 2003;15:178–184.
  12. Mataix-Cols D, Marks IM, Greist JH, Kobak KA, Baer L: Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychother Psychosom 2002;71:255–262.
  13. Stewart SE, Geller DA, Jenike M, Pauls D, Shaw D, Mullin B, Faraone SV: Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand 2004;110:4–13.
  14. Torres AR, Prince MJ, Bebbington PE, Bhugra D, Brugha TS, Farrell M, Jenkins R, Lewis G, Meltzer H, Singleton N: Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. Am J Psychiatry 2006;163:1978–1985.
  15. Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE: Local cerebral glucose metabolic rates in obsessive-compulsive disorder: a comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 1987;44:211–218.
  16. Baxter LR Jr, Schwartz JM, Mazziotta JC, Phelps ME, Pahl JJ, Guze BH, Fairbanks L: Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry 1988;145:1560–1563.
  17. Swedo SE, Schapiro MB, Grady CL, Cheslow DL, Leonard HL, Kumar A, Friedland R, Rapoport SI, Rapoport JL: Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989;46:518–523.
  18. Machlin SR, Harris GJ, Pearlson GD, Hoehn-Saric R, Jeffery P, Camargo EE: Elevated medial-frontal cerebral blood flow in obsessive-compulsive patients: a SPECT study. Am J Psychiatry 1991;148:1240–1242.
  19. Belliveau JW, Kennedy DN Jr, McKinstry RC, Buchbinder BR, Weisskoff RM, Cohen MS, Vevea JM, Brady TJ, Rosen BR: Functional mapping of the human visual cortex by magnetic resonance imaging. Science 1991;254:716–719.
  20. Bandettini PA, Wong EC, Hinks RS, Tikofsky RS, Hyde JS: Time course EPI of human brain function during task activation. Magn Reson Med 1992;25:390–397.
  21. Kwong KK, Belliveau JW, Chesler DA, Goldberg IE, Weisskoff RM, Poncelet BP, Kennedy DN, Hoppel BE, Cohen MS, Turner R: Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci USA 1992;89:5675–5679.
  22. Ogawa S, Tank DW, Menon R, Ellermann JM, Kim SG, Merkle H, Ugurbil K: Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci USA 1992;89:5951–5955.
  23. Baxter LR Jr, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, Alazraki A, Selin CE, Ferng HK, Munford P: Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49:681–689.
  24. Hoehn-Saric R, Pearlson GD, Harris GJ, Machlin SR, Camargo EE: Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Am J Psychiatry 1991;148:1243–1245.
  25. Swedo SE, Pietrini P, Leonard HL, Schapiro MB, Rettew DC, Goldberger EL, Rapoport SI, Rapoport JL, Grady CL: Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder: revisualization during pharmacotherapy. Arch Gen Psychiatry 1992;49:690–694.
  26. Cottraux J, Gérard D, Cinotti L, Froment JC, Deiber MP, le Bars D, Galy G, Millet P, Labbé C, Lavenne F, Bouvard M, Mauguière F: A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive-compulsive disorder with checking rituals. Psychiatry Res 1996;60:101–112.
  27. Jenike MA, Breiter HC, Baer L, Kennedy DN, Savage CR, Olivares MJ, O’Sullivan RL, Shera DM, Rauch SL, Keuthen N, Rosen BR, Caviness VS, Filipek PA: Cerebral structural abnormalities in obsessive-compulsive disorder: a quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry 1996;53:625–632.
  28. McGuire PK, Bench CJ, Frith CD, Marks IM, Frackowiak RS, Dolan RJ: Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry 1994;164:459–468.
  29. Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR, Fischman AJ: Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994;51:62–70.
  30. Zohar J, Insel TR, Berman KF, Foa EB, Hill JL, Weinberger DR: Anxiety and cerebral blood flow during behavioral challenge: dissociation of central from peripheral and subjective measures. Arch Gen Psychiatry 1989;46:505–510.
  31. Savage CR, Weilburg JB, Duffy FH, Baer L, Shera DM, Jenike MA: Low-level sensory processing in obsessive-compulsive disorder: an evoked potential study. Biol Psychiatry 1994;35:247–252.
  32. Towey J, Bruder G, Tenke C, Leite P, DeCaria C, Friedman D, Hollander E: Event-related potential and clinical correlates of neurodysfunction in obsessive-compulsive disorder. Psychiatry Res 1993;49:167–181.
  33. Garber HJ, Ananth JV, Chiu LC, Griswold VJ, Oldendorf WH: Nuclear magnetic resonance study of obsessive-compulsive disorder. Am J Psychiatry 1989;146:1001–1005.
  34. Ebert D, Speck O, König A, Berger M, Hennig J, Hohagen F: 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Res 1997;74:173–176.
  35. Perani D, Colombo C, Bressi S, Bonfanti A, Grassi F, Scarone S, Bellodi L, Smeraldi E, Fazio F: [18F]FDG PET study in obsessive-compulsive disorder: a clinical/metabolic correlation study after treatment. Br J Psychiatry 1995;166:244–250.
  36. Galderisi S, Mucci A, Catapano F, D’Amato AC, Maj M: Neuropsychological slowness in obsessive-compulsive patients: is it confined to tests involving the fronto-subcortical systems? Br J Psychiatry 1995;167:394–398.
  37. Ursu S, Stenger VA, Shear MK, Jones MR, Carter CS: Overactive action monitoring in obsessive-compulsive disorder: evidence from functional magnetic resonance imaging. Psychol Sci 2003;14:347–353.
  38. Fitzgerald KD, Welsh RC, Gehring WJ, Abelson JL, Himle JA, Liberzon I, Taylor SF: Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder. Biol Psychiatry 2005;57:287–294.
  39. Maltby N, Tolin DF, Worhunsky P, O’Keefe TM, Kiehl KA: Dysfunctional action monitoring hyperactivates frontal-striatal circuits in obsessive-compulsive disorder: an event-related fMRI study. Neuroimage 2005;24:495–503.
  40. Nakao T, Nakagawa A, Yoshiura T, Nakatani E, Nabeyama M, Yoshizato C, Kudoh A, Tada K, Yoshioka K, Kawamoto M: A functional MRI comparison of patients with obsessive-compulsive disorder and normal controls during a Chinese character Stroop task. Psychiatry Res 2005;139:101–114.
  41. Nabeyama M, Nakagawa A, Yoshiura T, Nakao T, Nakatani E, Togao O, Yoshizato C, Yoshioka K, Tomita M, Kanba S: Functional MRI study of brain activation alterations in patients with obsessive-compulsive disorder after symptom improvement. Psychiatry Res 2008;163:236–247.
  42. Viard A, Flament MF, Artiges E, Dehaene S, Naccache L, Cohen D, Mazet P, Mouren MC, Martinot JL: Cognitive control in childhood-onset obsessive-compulsive disorder: a functional MRI study. Psychol Med 2005;35:1007–1017.
  43. Adler CM, McDonough-Ryan P, Sax KW, Holland SK, Arndt S, Strakowski SM: fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder. J Psychiatr Res 2000;34:317–324.
  44. Breiter HC, Rauch SL: Functional MRI and the study of OCD: from symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala. Neuroimage 1996;4:S127–S138.
  45. Saxena S, Brody AL, Schwartz JM, Baxter LR: Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl 1998;35:26–37.
    External Resources
  46. Levy R, Goldman-Rakic PS: Segregation of working memory functions within the dorsolateral prefrontal cortex. Exp Brain Res 2000;133:23–32.
  47. Petrides M: Specialized systems for the processing of mnemonic information within the primate frontal cortex. Philos Trans R Soc Lond B Biol Sci 1996;351:1455–1461, discussion 1461–1462.
  48. Manoach DS, White NS, Lindgren KA, Heckers S, Coleman MJ, Dubal S, Holzman PS: Hemispheric specialization of the lateral prefrontal cortex for strategic processing during spatial and shape working memory. Neuroimage 2004;21:894–903.
  49. Petrides M: Frontal lobes and behaviour. Curr Opin Neurobiol 1994;4:207–211.
  50. Burgess PW, Veitch E, de Lacy Costello A, Shallice T: The cognitive and neuroanatomical correlates of multitasking. Neuropsychologia 2000;38:848–863.
  51. Bunge SA, Kahn I, Wallis JD, Miller EK, Wagner AD: Neural circuits subserving the retrieval and maintenance of abstract rules. J Neurophysiol 2003;90:3419–3428.
  52. Menon V, Mackenzie K, Rivera SM, Reiss AL: Prefrontal cortex involvement in processing incorrect arithmetic equations: evidence from event-related fMRI. Hum Brain Mapp 2002;16:119–130.
  53. van den Heuvel OA, Veltman DJ, Groenewegen HJ, Cath DC, van Balkom AJLM, van Hartskamp J, Barkhof F, van Dyck R: Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Arch Gen Psychiatry 2005;62:301–309.
  54. Gu BM, Park JY, Kang DH, Lee SJ, Yoo SY, Jo HJ, Choi CH, Lee JM, Kwon JS: Neural correlates of cognitive inflexibility during task-switching in obsessive-compulsive disorder. Brain 2008;131:155–164.
  55. van der Wee NJA, Ramsey NF, Jansma JM, Denys DA, van Megen HJGM, Westenberg HMG, Kahn RS: Spatial working memory deficits in obsessive compulsive disorder are associated with excessive engagement of the medial frontal cortex. Neuroimage 2003;20:2271–2280.
  56. Nakao T, Nakagawa A, Nakatani E, Nabeyama M, Sanematsu H, Yoshiura T, Togao O, Tomita M, Masuda Y, Yoshioka K, Kuroki T, Kanba S: Working memory dysfunction in obsessive-compulsive disorder: a neuropsychological and functional MRI study. J Psychiatr Res 2009;43:784–791.
  57. Nakao T, Nakagawa A, Yoshiura T, Nakatani E, Nabeyama M, Sanematsu H, Togao O, Yoshioka K, Tomita M, Kuroki T, Kanba S: Duration effect of obsessive-compulsive disorder on cognitive function: a functional MRI study. Depress Anxiety 2009;26:814–823.
  58. Levine JB, Gruber SA, Baird AA, Yurgelun-Todd D: Obsessive-compulsive disorder among schizophrenic patients: an exploratory study using functional magnetic resonance imaging data. Compr Psychiatry 1998;39:308–311.
  59. Aouizerate B, Guehl D, Cuny E, Rougier A, Bioulac B, Tignol J, Burbaud P: Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog Neurobiol 2004;72:195–221.
  60. Breiter HC, Rauch SL, Kwong KK, Baker JR, Weisskoff RM, Kennedy DN, Kendrick AD, Davis TL, Jiang A, Cohen MS, Stern CE, Belliveau JW, Baer L, O’Sullivan RL, Savage CR, Jenike MA, Rosen BR: Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry 1996;53:595–606.
  61. McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH: A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2000;57:794–801.
  62. Rogers RD, Blackshaw AJ, Middleton HC, Matthews K, Hawtin K, Crowley C, Hopwood A, Wallace C, Deakin JF, Sahakian BJ, Robbins TW: Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology 1999;146:482–491.
  63. Schultz W: Predictive reward signal of dopamine neurons. J Neurophysiol 1998;80:1–27.
  64. Abbruzzese M, Ferri S, Scarone S: The selective breakdown of frontal functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: a double dissociation experimental finding. Neuropsychologia 1997;35:907–912.
  65. Cavedini P, Riboldi G, D’Annucci A, Belotti P, Cisima M, Bellodi L: Decision-making heterogeneity in obsessive-compulsive disorder: ventromedial prefrontal cortex function predicts different treatment outcomes. Neuropsychologia 2002;40:205–211.
  66. Hermesh H, Zohar J, Weizman A, Voet H, Gross-Isseroff R: Orbitofrontal cortex dysfunction in obsessive-compulsive disorder? 2. Olfactory quality discrimination in obsessive-compulsive disorder. Eur Neuropsychopharmacol 1999;9:415–420.
  67. Nielen MMA, Veltman DJ, de Jong R, Mulder G, den Boer JA: Decision making performance in obsessive compulsive disorder. J Affect Disord 2002;69:257–260.
  68. Kim JJ, Lee MC, Kim J, Kim IY, Kim SI, Han MH, Chang KH, Kwon JS: Grey matter abnormalities in obsessive-compulsive disorder: statistical parametric mapping of segmented magnetic resonance images. Br J Psychiatry 2001;179:330–334.
  69. Pujol J, Soriano-Mas C, Alonso P, Cardoner N, Menchon JM, Deus J, Vallejo J: Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry 2004;61:720–730.
  70. Lacerda ALT, Dalgalarrondo P, Caetano D, Camargo EE, Etchebehere ECSC, Soares JC: Elevated thalamic and prefrontal regional cerebral blood flow in obsessive-compulsive disorder: a SPECT study. Psychiatry Res 2003;123:125–134.
  71. Busatto GF, Zamignani DR, Buchpiguel CA, Garrido GE, Glabus MF, Rocha ET, Maia AF, Rosario-Campos MC, Campi Castro C, Furuie SS, Gutierrez MA, McGuire PK, Miguel EC: A voxel-based investigation of regional cerebral blood flow abnormalities in obsessive-compulsive disorder using single photon emission computed tomography (SPECT). Psychiatry Res 2000;99:15–27.
  72. van den Heuvel OA, Veltman DJ, Groenewegen HJ, Dolan RJ, Cath DC, Boellaard R, Mesina CT, van Balkom AJLM, van Oppen P, Witter MP, Lammertsma AA, van Dyck R: Amygdala activity in obsessive-compulsive disorder with contamination fear: a study with oxygen-15 water positron emission tomography. Psychiatry Res 2004;132:225–237.
  73. Remijnse PL, Nielen MMA, van Balkom AJLM, Cath DC, van Oppen P, Uylings HBM, Veltman DJ: Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder. Arch Gen Psychiatry 2006;63:1225–1236.
  74. Rauch SL, Wedig MM, Wright CI, Martis B, McMullin KG, Shin LM, Cannistraro PA, Wilhelm S: Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder. Biol Psychiatry 2007;61:330–336.
  75. Baxter LR Jr: Basal ganglia systems in ritualistic social displays: reptiles and humans – function and illness. Physiol Behav 2003;79:451–460.
  76. Remijnse PL, Nielen MMA, van Balkom AJLM, Hendriks GJ, Hoogendijk WJ, Uylings HBM, Veltman DJ: Differential frontal-striatal and paralimbic activity during reversal learning in major depressive disorder and obsessive-compulsive disorder. Psychol Med 2009;39:1503–1518.
  77. Crespo-Facorro B, Cabranes JA, Lopez-Ibor Alcocer MI, Paya B, Fernandez Perez C, Encinas M, Ayuso Mateos JL, Lopez-Ibor JJ Jr: Regional cerebral blood flow in obsessive-compulsive patients with and without a chronic tic disorder: a SPECT study. Eur Arch Psychiatry Clin Neurosci 1999;249:156–161.
  78. Lucey JV, Costa DC, Blanes T, Busatto GF, Pilowsky LS, Takei N, Marks IM, Ell PJ, Kerwin RW: Regional cerebral blood flow in obsessive-compulsive disordered patients at rest: differential correlates with obsessive-compulsive and anxious-avoidant dimensions. Br J Psychiatry 1995;167:629–634.
  79. Roth RM, Saykin AJ, Flashman LA, Pixley HS, West JD, Mamourian AC: Event-related functional magnetic resonance imaging of response inhibition in obsessive-compulsive disorder. Biol Psychiatry 2007;62:901–909.
  80. Ullsperger M, von Cramon DY: Subprocesses of performance monitoring: a dissociation of error processing and response competition revealed by event-related fMRI and ERPs. Neuroimage 2001;14:1387–1401.
  81. Garavan H, Ross TJ, Kaufman J, Stein EA: A midline dissociation between error-processing and response-conflict monitoring. Neuroimage 2003;20:1132–1139.
  82. Yücel M, Harrison BJ, Wood SJ, Fornito A, Wellard RM, Pujol J, Clarke K, Phillips ML, Kyrios M, Velakoulis D, Pantelis C: Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder. Arch Gen Psychiatry 2007;64:946–955.
  83. Buckner RL, Raichle ME, Petersen SE: Dissociation of human prefrontal cortical areas across different speech production tasks and gender groups. J Neurophysiol 1995;74:2163–2173.
  84. Mummery CJ, Patterson K, Hodges JR, Wise RJ: Generating ‘tiger’ as an animal name or a word beginning with T: differences in brain activation. Proc Biol Sci 1996;263:989–995.
  85. Pujol J, Vendrell P, Deus J, Kulisevsky J, Martí-Vilalta JL, García C, Junqué C, Capdevila A: Frontal lobe activation during word generation studied by functional MRI. Acta Neurol Scand 1996;93:403–410.
  86. Cuenod CA, Bookheimer SY, Hertz-Pannier L, Zeffiro TA, Theodore WH, le Bihan D: Functional MRI during word generation, using conventional equipment: a potential tool for language localization in the clinical environment. Neurology 1995;45:1821–1827.
  87. Rueckert L, Appollonio I, Grafman J, Jezzard P, Johnson R Jr, le Bihan D, Turner R: Magnetic resonance imaging functional activation of left frontal cortex during covert word production. J Neuroimaging 1994;4:67–70.
  88. Yetkin FZ, Hammeke TA, Swanson SJ, Morris GL, Mueller WM, McAuliffe TL, Haughton VM: A comparison of functional MR activation patterns during silent and audible language tasks. AJNR Am J Neuroradiol 1995;16:1087–1092.
  89. Yurgelun-Todd DA, Waternaux CM, Cohen BM, Gruber SA, English CD, Renshaw PF: Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. Am J Psychiatry 1996;153:200–205.
  90. Christensen KJ, Kim SW, Dysken MW, Hoover KM: Neuropsychological performance in obsessive-compulsive disorder. Biol Psychiatry 1992;31:4–18.
  91. Otto MW: Normal and abnormal information processing: a neuropsychological perspective on obsessive-compulsive disorder. Psychiatr Clin North Am 1992;15:825–848.
  92. Henseler I, Gruber O, Kraft S, Krick C, Reith W, Falkai P: Compensatory hyperactivations as markers of latent working memory dysfunctions in patients with obsessive-compulsive disorder: an fMRI study. J Psychiatry Neurosci 2008;33:209–215.
  93. Lázaro L, Caldú X, Junqué C, Bargalló N, Andrés S, Morer A, Castro-Fornieles J: Cerebral activation in children and adolescents with obsessive-compulsive disorder before and after treatment: a functional MRI study. J Psychiatr Res 2008;42:1051–1059.
  94. Jung WH, Gu BM, Kang DH, Park JY, Yoo SY, Choi CH, Lee JM, Kwon JS: BOLD response during visual perception of biological motion in obsessive-compulsive disorder: an fMRI study using the dynamic point-light animation paradigm. Eur Arch Psychiatry Clin Neurosci 2009;259:46–54.
  95. Simpson S, Baldwin B: Neuropsychiatry and SPECT of an acute obsessive-compulsive syndrome patient. Br J Psychiatry 1995;166:390–392.
  96. Berthier ML, Kulisevsky J, Gironell A, Heras JA: Obsessive-compulsive disorder associated with brain lesions: clinical phenomenology, cognitive function, and anatomic correlates. Neurology 1996;47:353–361.
  97. Hendler T, Goshen E, Tadmor R, Lustig M, Zwas ST, Zohar J: Evidence for striatal modulation in the presence of fixed cortical injury in obsessive-compulsive disorder (OCD). Eur Neuropsychopharmacol 1999;9:371–376.
  98. Walker SC, Robbins TW, Roberts AC: Differential contributions of dopamine and serotonin to orbitofrontal cortex function in the marmoset. Cereb Cortex 2009;19:889–898.
  99. Koepp MJ, Gunn RN, Lawrence AD, Cunningham VJ, Dagher A, Jones T, Brooks DJ, Bench CJ, Grasby PM: Evidence for striatal dopamine release during a video game. Nature 1998;393:266–268.
  100. Schilman EA, Klavir O, Winter C, Sohr R, Joel D: The role of the striatum in compulsive behavior in intact and orbitofrontal-cortex-lesioned rats: possible involvement of the serotonergic system. Neuropsychopharmacology 2010;35:1026–1039.
  101. van der Wee NJ, Stevens H, Hardeman JA, Mandl RC, Denys DA, van Megen HJ, Kahn RS, Westenberg HM: Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]β-CIT SPECT. Am J Psychiatry 2004;161:2201–2206.
  102. Denys D, van der Wee N, Janssen J, de Geus F, Westenberg HGM: Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Biol Psychiatry 2004;55:1041–1045.
  103. Alexander GE, DeLong MR, Strick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357–381.
  104. Knopman D, Nissen MJ: Procedural learning is impaired in Huntington’s disease: evidence from the serial reaction time task. Neuropsychologia 1991;29:245–254.
  105. Aylward EH, Harris GJ, Hoehn-Saric R, Barta PE, Machlin SR, Pearlson GD: Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging. Arch Gen Psychiatry 1996;53:577–584.
  106. Robinson D, Wu H, Munne RA, Ashtari M, Alvir JM, Lerner G, Koreen A, Cole K, Bogerts B: Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry 1995;52:393–398.
  107. Rubin RT, Villanueva-Meyer J, Ananth J, Trajmar PG, Mena I: Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects: determination by high-resolution single-photon emission computed tomography. Arch Gen Psychiatry 1992;49:695–702.
  108. Saxena S, Brody AL, Maidment KM, Smith EC, Zohrabi N, Katz E, Baker SK, Baxter LR Jr: Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry 2004;161:1038–1048.
  109. Deckersbach T, Savage CR, Curran T, Bohne A, Wilhelm S, Baer L, Jenike MA, Rauch SL: A study of parallel implicit and explicit information processing in patients with obsessive-compulsive disorder. Am J Psychiatry 2002;159:1780–1782.
  110. Rauch SL, Savage CR: Neuroimaging and neuropsychology of the striatum: bridging basic science and clinical practice. Psychiatr Clin North Am 1997;20:741–768.
  111. Nakao T, Nakagawa A, Yoshiura T, Nakatani E, Nabeyama M, Yoshizato C, Kudoh A, Tada K, Yoshioka K, Kawamoto M, Togao O, Kanba S: Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Biol Psychiatry 2005;57:901–910.
  112. Benkelfat C, Nordahl TE, Semple WE, King AC, Murphy DL, Cohen RM: Local cerebral glucose metabolic rates in obsessive-compulsive disorder: patients treated with clomipramine. Arch Gen Psychiatry 1990;47:840–848.
  113. Rauch SL, Jenike MA: Neurobiological models of obsessive-compulsive disorder. Psychosomatics 1993;34:20–32.
  114. Rauch SL, Savage CR, Alpert NM, Dougherty D, Kendrick A, Curran T, Brown HD, Manzo P, Fischman AJ, Jenike MA: Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning. J Neuropsychiatry Clin Neurosci 1997;9:568–573.
  115. Purcell R, Maruff P, Kyrios M, Pantelis C: Cognitive deficits in obsessive-compulsive disorder on tests of frontal-striatal function. Biol Psychiatry 1998;43:348–357.
  116. Purcell R, Maruff P, Kyrios M, Pantelis C: Neuropsychological deficits in obsessive-compulsive disorder: a comparison with unipolar depression, panic disorder, and normal controls. Arch Gen Psychiatry 1998;55:415–423.
  117. Mataix-Cols D, Junqué C, Sànchez-Turet M, Vallejo J, Verger K, Barrios M: Neuropsychological functioning in a subclinical obsessive-compulsive sample. Biol Psychiatry 1999;45:898–904.
  118. Schmidtke K, Schorb A, Winkelmann G, Hohagen F: Cognitive frontal lobe dysfunction in obsessive-compulsive disorder. Biol Psychiatry 1998;43:666–673.
  119. Veale DM, Sahakian BJ, Owen AM, Marks IM: Specific cognitive deficits in tests sensitive to frontal lobe dysfunction in obsessive-compulsive disorder. Psychol Med 1996;26:1261–1269.
  120. Keith Berg W, Byrd D: The Tower of London spatial problem-solving task: enhancing clinical and research implementation. J Clin Exp Neuropsychol 2002;24:586–604.
  121. Cahill L, Haier RJ, Fallon J, Alkire MT, Tang C, Keator D, Wu J, McGaugh JL: Amygdala activity at encoding correlated with long-term, free recall of emotional information. Proc Natl Acad Sci USA 1996;93:8016–8021.
  122. Corbetta M, Shulman GL, Miezin FM, Petersen SE: Superior parietal cortex activation during spatial attention shifts and visual feature conjunction. Science 1995;270:802–805.
  123. Courchesne E, Townsend J, Akshoomoff NA, Saitoh O, Yeung-Courchesne R, Lincoln AJ, James HE, Haas RH, Schreibman L, Lau L: Impairment in shifting attention in autistic and cerebellar patients. Behav Neurosci 1994;108:848–865.
  124. Kim SG, Ugurbil K, Strick PL: Activation of a cerebellar output nucleus during cognitive processing. Science 1994;265:949–951.
  125. Le TH, Pardo JV, Hu X: 4 T-fMRI study of nonspatial shifting of selective attention: cerebellar and parietal contributions. J Neurophysiol 1998;79:1535–1548.
  126. Schmahmann JD, Pandya DN: Prefrontal cortex projections to the basilar pons in rhesus monkey: implications for the cerebellar contribution to higher function. Neurosci Lett 1995;199:175–178.
  127. Schmahmann JD, Pandya DN: Anatomical investigation of projections to the basis pontis from posterior parietal association cortices in rhesus monkey. J Comp Neurol 1989;289:53–73.
  128. Schmahmann JD, Pandya DN: Prelunate, occipitotemporal, and parahippocampal projections to the basis pontis in rhesus monkey. J Comp Neurol 1993;337:94–112.
  129. Vilensky JA, van Hoesen GW: Corticopontine projections from the cingulate cortex in the rhesus monkey. Brain Res 1981;205:391–395.
  130. Schmahmann JD, Sherman JC: The cerebellar cognitive affective syndrome. Brain 1998;121(pt 4):561–579.
  131. Page LA, Rubia K, Deeley Q, Daly E, Toal F, Mataix-Cols D, Giampietro V, Schmitz N, Murphy DGM: A functional magnetic resonance imaging study of inhibitory control in obsessive-compulsive disorder. Psychiatry Res 2009;174:202–209.
  132. Sanematsu H, Nakao T, Yoshiura T, Nabeyama M, Togao O, Tomita M, Masuda Y, Nakatani E, Nakagawa A, Kanba S: Predictors of treatment response to fluvoxamine in obsessive-compulsive disorder: an fMRI study. J Psychiatr Res 2010;44:193–200.
  133. Kang DH, Kwon JS, Kim JJ, Youn T, Park HJ, Kim MS, Lee DS, Lee MC: Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessive-compulsive disorder. Acta Psychiatr Scand 2003;107:291–297.
  134. Rauch SL, Baxter LR: Neuroimaging of OCD and related disorders; in Jenike MA, Baer L, Minichiello WE (eds): Obsessive-Compulsive Disorders. Theory and Management. St. Louis, Mosby, 1998, pp 289–317.
  135. Nordahl TE, Benkelfat C, Semple WE, Gross M, King AC, Cohen RM: Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology 1989;2:23–28.
  136. Brody AL, Saxena S, Schwartz JM, Stoessel PW, Maidment K, Phelps ME, Baxter LR Jr: FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive-compulsive disorder. Psychiatry Res 1998;84:1–6.
  137. Schwartz JM, Stoessel PW, Baxter LR Jr, Martin KM, Phelps ME: Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1996;53:109–113.
  138. Rauch SL, Dougherty DD, Cosgrove GR, Cassem EH, Alpert NM, Price BH, Nierenberg AA, Mayberg HS, Baer L, Jenike MA, Fischman AJ: Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder. Biol Psychiatry 2001;50:659–667.
  139. Saxena S, Brody AL, Maidment KM, Dunkin JJ, Colgan M, Alborzian S, Phelps ME, Baxter LR Jr: Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 1999;21:683–693.
  140. Deckersbach T, Dougherty DD, Rauch SL: Functional imaging of mood and anxiety disorders. J Neuroimaging 2006;16:1–10.
  141. Mataix-Cols D, Rosario-Campos MC, Leckman JF: A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005;162:228–238.
  142. Miguel EC, Leckman JF, Rauch S, do Rosario-Campos MC, Hounie AG, Mercadante MT, Chacon P, Pauls DL: Obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry 2005;10:258–275.
  143. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, Alsobrook J, Peterson BS, Cohen DJ, Rasmussen SA, Goodman WK, McDougle CJ, Pauls DL: Symptoms of obsessive-compulsive disorder. Am J Psychiatry 1997;154:911–917.
  144. Baer L: Factor analysis of symptom subtypes of obsessive-compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry 1994;55(suppl): 18–23.
  145. Summerfeldt LJ, Richter MA, Antony MM, Swinson RP: Symptom structure in obsessive-compulsive disorder: a confirmatory factor-analytic study. Behav Res Ther 1999;37:297–311.
  146. Mataix-Cols D, Rauch SL, Baer L, Eisen JL, Shera DM, Goodman WK, Rasmussen SA, Jenike MA: Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study. Am J Psychiatry 2002;159:263–268.
  147. Alsobrook JP 2nd, Leckman JF, Goodman WK, Rasmussen SA, Pauls DL: Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet 1999;88:669–675.
  148. Leckman JF, Pauls DL, Zhang H, Rosario-Campos MC, Katsovich L, Kidd KK, Pakstis AJ, Alsobrook JP, Robertson MM, McMahon WM, Walkup JT, van de Wetering BJM, King RA, Cohen DJ: Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome. Am J Med Genet B Neuropsychiatr Genet 2003;116B:60–68.
  149. Zhang H, Leckman JF, Pauls DL, Tsai CP, Kidd KK, Campos MR: Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. Am J Hum Genet 2002;70:896–904.
  150. Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML: Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 2004;61:564–576.
  151. Gilbert AR, Akkal D, Almeida JRC, Mataix-Cols D, Kalas C, Devlin B, Birmaher B, Phillips ML: Neural correlates of symptom dimensions in pediatric obsessive-compulsive disorder: a functional magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry 2009;48:936–944.
  152. Rubia K, Cubillo A, Smith AB, Woolley J, Heyman I, Brammer MJ: Disorder-specific dysfunction in right inferior prefrontal cortex during two inhibition tasks in boys with attention-deficit hyperactivity disorder compared to boys with obsessive-compulsive disorder. Hum Brain Mapp 2010;31:287–299.
  153. Woolley J, Heyman I, Brammer M, Frampton I, McGuire PK, Rubia K: Brain activation in paediatric obsessive compulsive disorder during tasks of inhibitory control. Br J Psychiatry 2008;192:25–31.
  154. Rosenberg DR, Keshavan MS, O’Hearn KM, Dick EL, Bagwell WW, Seymour AB, Montrose DM, Pierri JN, Birmaher B: Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Arch Gen Psychiatry 1997;54:824–830.
  155. Szeszko PR, MacMillan S, McMeniman M, Chen S, Baribault K, Lim KO, Ivey J, Rose M, Banerjee SP, Bhandari R, Moore GJ, Rosenberg DR: Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry 2004;161:1049–1056.
  156. Gilbert AR, Moore GJ, Keshavan MS, Paulson LA, Narula V, Mac Master FP, Stewart CM, Rosenberg DR: Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry 2000;57:449–456.
  157. Austin MP, Mitchell P, Goodwin GM: Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 2001;178:200–206.
  158. Swaab DF, Fliers E, Hoogendijk WJ, Veltman DJ, Zhou JN: Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression. Prog Brain Res 2000;126:369–396.
  159. Saxena S, Brody AL, Ho ML, Alborzian S, Ho MK, Maidment KM, Huang SC, Wu HM, Au SC, Baxter LR Jr: Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol Psychiatry 2001;50:159–170.
  160. Greisberg S, McKay D: Neuropsychology of obsessive-compulsive disorder: a review and treatment implications. Clin Psychol Rev 2003;23:95–117.
  161. Dehaene S, Changeux JP: A hierarchical neuronal network for planning behavior. Proc Natl Acad Sci USA 1997;94:13293–13298.
  162. Anzai Y, Simon HA: The theory of learning by doing. Psychol Rev 1979;86:124–140.
  163. Shallice T: Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci 1982;298:199–209.
  164. Baker SC, Rogers RD, Owen AM, Frith CD, Dolan RJ, Frackowiak RS, Robbins TW: Neural systems engaged by planning: a PET study of the Tower of London task. Neuropsychologia 1996;34:515–526.
  165. Dagher A, Owen AM, Boecker H, Brooks DJ: Mapping the network for planning: a correlational PET activation study with the Tower of London task. Brain 1999;122(pt 10):1973–1987.
  166. Owen AM, Doyon J, Petrides M, Evans AC: Planning and spatial working memory: a positron emission tomography study in humans. Eur J Neurosci 1996;8:353–364.
  167. Rowe JB, Owen AM, Johnsrude IS, Passingham RE: Imaging the mental components of a planning task. Neuropsychologia 2001;39:315–327.
  168. Morris RG, Ahmed S, Syed GM, Toone BK: Neural correlates of planning ability: frontal lobe activation during the Tower of London test. Neuropsychologia 1993;31:1367–1378.
  169. Rezai K, Andreasen NC, Alliger R, Cohen G, Swayze V 2nd, O’Leary DS: The neuropsychology of the prefrontal cortex. Arch Neurol 1993;50:636–642.
  170. Cazalis F, Valabregue R, Pelegrini-Issac M, Asloun S, Robbins TW, Granon S: Individual differences in prefrontal cortical activation on the Tower of London planning task: implication for effortful processing. Eur J Neurosci 2003;17:2219–2225.
  171. Fincham JM, Carter CS, van Veen V, Stenger VA, Anderson JR: Neural mechanisms of planning: a computational analysis using event-related fMRI. Proc Natl Acad Sci USA 2002;99:3346–3351.
  172. Lazeron RH, Rombouts SA, Machielsen WC, Scheltens P, Witter MP, Uylings HB, Barkhof F: Visualizing brain activation during planning: the Tower of London test adapted for functional MR imaging. AJNR Am J Neuroradiol 2000;21:1407–1414.
  173. Newman SD, Carpenter PA, Varma S, Just MA: Frontal and parietal participation in problem solving in the Tower of London: fMRI and computational modeling of planning and high-level perception. Neuropsychologia 2003;41:1668–1682.
  174. van den Heuvel OA, Groenewegen HJ, Barkhof F, Lazeron RHC, van Dyck R, Veltman DJ: Frontostriatal system in planning complexity: a parametric functional magnetic resonance version of Tower of London task. Neuroimage 2003;18:367–374.
  175. Pujol J, Torres L, Deus J, Cardoner N, Pifarré J, Capdevila A, Vallejo J: Functional magnetic resonance imaging study of frontal lobe activation during word generation in obsessive-compulsive disorder. Biol Psychiatry 1999;45:891–897.
  176. Ursu S, Carter CS: An initial investigation of the orbitofrontal cortex hyperactivity in obsessive-compulsive disorder: exaggerated representations of anticipated aversive events? Neuropsychologia 2009;47:2145–2148.
  177. Martinot JL, Hardy P, Feline A, Huret JD, Mazoyer B, Attar-Levy D, Pappata S, Syrota A: Left prefrontal glucose hypometabolism in the depressed state: a confirmation. Am J Psychiatry 1990;147:1313–1317.
  178. Sawle GV, Hymas NF, Lees AJ, Frackowiak RS: Obsessional slowness: functional studies with positron emission tomography. Brain 1991;114:2191–2202.
  179. Rauch SL, Shin LM, Dougherty DD, Alpert NM, Fischman AJ, Jenike MA: Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study. Neuropsychopharmacology 2002;27:782–791.
  180. Lucey JV, Costa DC, Busatto G, Pilowsky LS, Marks IM, Ell PJ, Kerwin RW: Caudate regional cerebral blood flow in obsessive-compulsive disorder, panic disorder and healthy controls on single photon emission computerised tomography. Psychiatry Res 1997;74:25–33.
  181. Bartha R, Stein MB, Williamson PC, Drost DJ, Neufeld RW, Carr TJ, Canaran G, Densmore M, Anderson G, Siddiqui AR: A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry 1998;155:1584–1591.
  182. Alptekin K, Degirmenci B, Kivircik B, Durak H, Yemez B, Derebek E, Tunca Z: Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive-compulsive patients without depression. Psychiatry Res 2001;107:51–56.